3,4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function

European Journal of Pharmacology

Volumn 349, Issue 2-3, 1998, Pages 205-210

  Metzger, Ryan R ^b   Hanson, Glen R ^a   Gibb, James W ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Dopamine transporter; MDMA (Methylenedioxymethamphetamine); Methamphetamine; Methcathinone; Oxygen species, reactive; p Chloramphetamine; Striatum

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CHLORAMPHETAMINE; COCAINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; METHCATHINONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; DOSE RESPONSE; DRUG COMPARISON; IN VITRO STUDY; ISOTOPE LABELING; MALE; MONOAMINERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CARRIER PROTEINS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HALLUCINOGENS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEOSTRIATUM; NERVE TISSUE PROTEINS; PROPIOPHENONES; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES;

EID: 0032557670     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00196-4     Document Type: Article

References (36)

1. 3H ]paroxetine-labeled serotonin uptake sites J. Pharmacol. Exp. Ther. 242:1987;911-916.
2. Berman S.B., Zigmond M.J., Hastings T.G. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67:1996;593-600.
3. Boja J.W., McNeill R.M., Lewin A.H., Abraham P., Carroll F.I., Kuhar M.J. Selective dopamine transport inhibition by cocaine analogs. NeuroReport. 3:1992;984-986.
4. Cadet J.L., Ladenheim B., Hirata H., Rothman R.B., Ali S., Carlson E., Epstein C., Moran T.H. Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice. Synapse. 21:1995;169-176.
5. Church W.H., Justice J.B., Byrd L.D. Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine. Eur. J. Pharmacol. 139:1987;345-348.
6. Colado M.I., Green A.R. The spin trap reagent α-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones. Eur. J. Pharmacol. 280:1995;343-348.
7. Fisher J.F., Cho A.K. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208:1979;203-209.
8. Fleckenstein A.E., Pögün S., Carroll F.I., Kuhar M.J. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 {3β-(3-p-chlorophenyl)tropan-2β-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride}. J. Pharmacol. Exp. Ther. 279:1996;200-206.
9. Fleckenstein A.E., Metzger R.R., Beyeler M.L., Gibb J.W., Hanson G.R. Oxygen radicals diminish dopamine transporter function in rat striatum. Eur. J. Pharmacol. 334:1997;111-114.
10. Fleckenstein A.E., Metzger R.R., Wilkins D.G., Gibb J.W., Hanson G.R. Rapid and reversible effects of methamphetamine on dopamine transporters. J. Pharmacol. Exp. Ther. 282:1997;834-838.
11. Fleckenstein A.E., Wilkins D.G., Gibb J.W., Hanson G.R. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J. Pharmacol. Exp. Ther. 283:1997;281-285.
12. Giovanni A., Liang L.P., Hastings T.G., Zigmond M.J. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64:1995;1819-1825.
13. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
14. Glennon R.A., Yousif M., Naiman N., Kalix P. Methcathinone: a new and potent amphetamine-like agent. Pharmacol. Biochem. Behav. 26:1987;547-551.
15. Graham D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14:1978;633-643.
16. Green A.R., Cross A.J., Goodwin G.M. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy'). Psychopharmacology. 119:1995;247-260.
17. Gygi M.P., Gibb J.W., Hanson G.R. Methcathinone: an initial study of its effects on monoaminergic systems. J. Pharmacol. Exp. Ther. 276:1996;1066-1072.
18. Hirata H., Ladenheim B., Rothman R.B., Epstein C., Cadet J.L. Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res. 677:1995;345-347.
19. Huang, N.K., Chaung, S.H., Lee, H.Y., Tung, C.S., 1996. Amphetamine induces hydroxyl radical formation in the striatum of rats. Soc. Neurosci., Abstract, 815.6.
20. Johnson M.P., Huang X.M., Oberlender R., Nash J.F., Nichols D.E. Behavioral, biochemical and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine. Eur. J. Pharmacol. 191:1990;1-10.
21. Kondo T., Ito T., Sugita Y. Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum. Ann. NY Acad. Sci. 738:1994;222-229.
22. 3H ]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine Biochem. Pharmacol. 31:1982;983-992.
23. Metzger, R.R., Fleckenstein, A.E., Beyeler, M.L., Gibb, J.W., Hanson, G.R., 1996. Effects of reactive oxygen species on dopamine transporter function in rat striatum: implications for methamphetamine toxicity. Soc. Neurosci., Abstract, 815.5.
24. Nash J.F., Nichols D.E. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues. Eur. J. Pharmacol. 200:1991;53-58.
25. Nash J.F., Yamamoto B.K. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581:1992;237-243.
26. O'Hearn E., Battaglia G., de Souza E.B., Kuhar M.J., Molliver M.E. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8:1988;2788-2803.
27. 3H ]dopamine uptake Brain Res. 641:1994;83-91.
28. Ricaurte G.A., Markowska A.L., Wenk G.L., Hatzidimitriou G., Wlos J., Olton D.S. 3,4-Methylenedioxymethamphetamine, serotonin and memory. J. Pharmacol. Exp. Ther. 266:1993;1097-1105.
29. Sanders-Bush E., Bushing J.A., Sulser F. Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms. J. Pharmacol. Exp. Ther. 192:1975;33-41.
30. Schmidt C.J., Taylor V.L. Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors. Eur. J. Pharmacol. 181:1990;133-136.
31. Sharpe T., Zetterstrom T., Christmanson L., Ungerstedt U. p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neurosci. Lett. 72:1986;320-324.
32. Stone D.M., Stahl D.C., Hanson G.R., Gibb J.W. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur. J. Pharmacol. 128:1986;41-48.
33. Stone D.M., Merchant K.M., Hanson G.R., Gibb J.W. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology. 26:1987;1677-1683.
34. Stone D.M., Johnson M., Hanson G.R., Gibb J.W. Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 172:1989;93-97.
35. Volterra A., Trotti D., Floridi S., Racagni G. Reactive oxygen species inhibit high-affinity glutamate uptake: molecular mechanism and neuropathological implications. Ann. NY Acad. Sci. 738:1994;153-162.
36. Wagner G.C., Ricaurte G.A., Seiden L.S., Schuster C.R., Miller R.J., Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181:1980;151-160.